Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


CONTINUING MEDICAL EDUCATION INFORMATION

Release Date: October 24, 2013
Last Reviewed: October 21, 2013
Expiration Date: October 24, 2014
Time to Complete Activity: 15 minutes

TARGET AUDIENCE

This activity has been designed to meet the educational needs of physicians with an interest in Diabetes/Endocrinology, as well as other health care professionals.

STATEMENT OF NEED

This activity will supply up-to-date news information to practicing clinicians which can be integrated into practice and aims to increase professional competency.

EDUCATIONAL OBJECTIVES

Upon proper completion of this activity, participants should be better able to:

  • Summarize the significance of the study in the context of clinical care.

DISCLOSURES

In accordance with Accreditation Council for Continuing Medical Education requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below.

Neither Paradigm Medical Communications, LLC, staff nor HealthDay's medical writer have financial relationships to disclose.

Peer reviewer, Cynthia Haines, M.D., has the following financial relationships to disclose:

  • Salary/Ownership Interest (stocks, stock options, or other ownership interest) - GlaxoSmithKline (Spouse)
Race/Ethnicity Has No Impact on Long-Term Mortality in T2DM
Long-term risk of death and death/MI/stroke does not vary with race/ethnicity

THURSDAY, Oct. 24 (HealthDay News) -- For adults with type 2 diabetes and coronary artery disease, race/ethnicity has no significant impact on the long-term risk of death, according to a study published in the Nov. 1 issue of The American Journal of Cardiology.

As part of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial, Nirat Beohar, M.D., from Columbia University in Miami Beach, and colleagues examined the impact of race/ethnicity on cardiovascular risk factor control and on clinical outcomes in a setting with comparable access to medical care. A total of 1,750 adults with type 2 diabetes and coronary artery disease from the United States and Canada were enrolled in the BARI 2D trial, and included 1,189 non-Hispanic whites, 349 non-Hispanic blacks, and 212 Hispanics. Participants were randomized to receive cardiac and glycemic treatment strategies.

During an average follow-up of 5.3 years, the researchers observed no significant variation by race/ethnicity in the long-term risk of death and death/myocardial infarction/stroke (five-year death: 11.0 percent whites; 13.7 percent blacks; 8.7 percent Hispanics; P = 0.19). For the 1,168 patients with suboptimal risk factor control at baseline, higher five-year survival was associated with the ability to attain better risk factor control (71, 86, and 95 percent, respectively, for patients with one, two, or three factors in control); this pattern was seen for all race/ethnicities.

"In conclusion, significant race/ethnic differences in cardiac risk profiles that persisted during follow-up did not translate into significant differences in five-year death or death/myocardial infarction/stroke," the authors write.

The BARI 2D Trial received funding, medications, and supplies from pharmaceutical companies.

Abstract
Full Text (subscription or payment may be required)


To earn CME credits for reading this article, click here

Copyright © 2013 HealthDay. All rights reserved.

August 1, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

Advanced Care Decision Aids Underutilized

Higher Risk of Vascular Events With Polymyalgia Rheumatica CME

Jump in Doctor's Office Visits for Young Adults With Diabetes

Weight Loss Intervention in T2DM Linked to Bone Loss CME

CDC Issues Travel Warning As Africa Ebola Outbreak Worsens

FDA Approves Once-Daily, Long-Acting Inhaler for COPD